Crossmark

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis

Crossref DOI link: https://doi.org/10.1186/s12964-019-0344-4

Published Online: 2019-03-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qin, Yi

Hu, Qiangsheng

Xu, Jin

Ji, Shunrong

Dai, Weixing

Liu, Wensheng

Xu, Wenyan

Sun, Qiqing

Zhang, Zheng

Ni, Quanxing

Zhang, Bo

Yu, Xianjun https://orcid.org/0000-0002-6697-7143
Xu, Xiaowu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81871950 and 81502031)

National Natural Science Foundation of China (81602085)

National Natural Science Foundation of China (81772555)

National Natural Science Foundation of China (81625016)

Shanghai Municipal Health Bureau (20154Y0090)

Shanghai Municipal Health Bureau (2018YQ06)

Shanghai Sailing Program (16YF1401800)
License Information

Text and Data Mining valid from 2019-03-29
More Information

Article History

Received: 19 October 2018

Accepted: 19 March 2019

First Online: 29 March 2019

Authors’ information

: Not applicable.

: The research protocol was reviewed and approved by the Ethics Committee of FDUSCC. This study complied with the Animal Care guidelines of FDUSCC.

: All of the authors listed consented to publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.